Inventor · disambiguated record
Mark C. Noe
Also filed as: NOE MARK C · NOE MARK CARL
15 granted patents·7 pending applications·685 citations·filing 1999–2022
95Inventor score
Top patents by PatentIndex Score
22 records- 0198US6235764B1Isothiazole derivatives useful as anticancer agentsPFIZER·Filed 1999·Granted May 22, 2001·261 cites·23 claims
- 0294US7030242B2Selective inhibition of aggrecanase in osteoarthritis treatmentPFIZER PROD INC·Filed 2005·Granted Apr 18, 2006·40 cites·3 claims
- 0394US6841671B2Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitorsPFIZER·Filed 2001·Granted Jan 11, 2005·39 cites·34 claims
- 0493US6380214B1Heterocyclic derivatives useful as anticancer agentsPFIZER·Filed 2000·Granted Apr 30, 2002·61 cites·2 claims
- 0592US7790902B2Isothiazole derivatives useful as anticancer agentsPFIZER·Filed 2008·Granted Sep 7, 2010·13 cites·2 claims
- 0692US6919332B2N-substituted-heteroaryloxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitorsPFIZER·Filed 2003·Granted Jul 19, 2005·82 cites·17 claims
- 0792US6900201B2N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitorsPFIZER·Filed 2003·Granted May 31, 2005·65 cites·33 claims
- 0889US6916807B2Triaryl-oxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitorsPFIZER·Filed 2003·Granted Jul 12, 2005·39 cites·47 claims
- 0989US6548526B2Isothiazole derivatives useful as anticancer agentsPFIZER·Filed 2001·Granted Apr 15, 2003·25 cites·18 claims
- 1084US6599890B1Arylsulfonyl hydroxamic acid derivativesPFIZER·Filed 2000·Granted Jul 29, 2003·22 cites·8 claims
- 1181US6706723B2Pyrimidine-2,4,6-trione metalloproteinase inhibitorsPFIZER·Filed 2001·Granted Mar 16, 2004·14 cites·17 claims
- 1278US6608104B2Gem substituted hydroxamic acidsPFIZER·Filed 2001·Granted Aug 19, 2003·13 cites·28 claims
- 1377US7462600B2MacrolidesPFIZER·Filed 2005·Granted Dec 9, 2008·3 cites·30 claims
- 1457US2024122865A1Methods of Protecting RNAPFIZER·Filed 2022·Application pending·0 cites
- 1555US7405218B2Isothiazole derivatives useful as anticancer agentsPFIZER·Filed 2003·Granted Jul 29, 2008·0 cites·2 claims
- 1651US6329397B1Hydroxy pipecolate hydroxamic acid derivativesPFIZER·Filed 1999·Granted Dec 11, 2001·8 cites·68 claims
- 1751US2005107414A1Pyrimidine-2,4,6-trione metalloproteinase inhibitorsFiled 2004·Application pending·0 cites
- 1851US2005159413A1Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitorsFiled 2004·Application pending·0 cites
- 1950US2005215549A1TACE inhibitorsMCCLURE KIM F·Filed 2005·Application pending·0 cites
- 2047US2003008901A1Hydroxy pipecolate hydroxamic acid derivativesFiled 2001·Application pending·0 cites
- 2145US2008293646A1MacrolidesPFIZER·Filed 2008·Application pending·0 cites
- 2231US2003181441A1Tace inhibitorsFiled 1999·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →